CJC-1295 DAC Information

CJC-1295 DAC (Drug Affinity Complex) is a synthetic peptide hormone used in the field of medical research and performance enhancement. It is a modified form of the growth hormone-releasing hormone (GHRH) that stimulates the release of growth hormone (GH) from the pituitary gland.

CJC-1295 DAC works by binding to and activating the GHRH receptors in the anterior pituitary gland, which then triggers the release of growth hormone. This leads to an increase in the production and secretion of GH, which has various physiological effects on the body.

One of the key advantages of CJC-1295 DAC is its extended half-life compared to other GHRH peptides. The addition of DAC, a drug affinity complex, helps to prolong the activity of the peptide in the body by binding to albumin and other proteins, preventing its rapid degradation. This allows for a more sustained release of growth hormone over an extended period.

The increased levels of growth hormone induced by CJC-1295 DAC can have several potential benefits, including enhanced muscle growth and recovery, improved fat metabolism, increased bone density, improved immune function, and anti-aging effects. However, it is important to note that the use of CJC-1295 DAC for performance enhancement purposes is not approved by regulatory authorities and is considered illegal in many sports.